Showing 10 of 10 recruiting trials for “cerebral-autosomal-dominant-arteriopathy-subcortical-infarcts-leukoencephalopathy”
RecruitingNCT06190834 ↗
Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.
RecruitingNCT06148051 ↗
AusCADASIL: An Australian Cohort of CADASIL
👨⚕️ Perminder S Sachdev, MBBS, MD, PhD, FRANZCP, FAAHMS, University of New South Wales📍 5 sites📅 Started Nov 2023View details ↗
RecruitingNCT06938100 ↗
Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL
RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
👨⚕️ Kenneth Offit, MD, MPH, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Dec 2022View details ↗
RecruitingNCT05072483 ↗
Natural History Study of CADASIL
👨⚕️ Elisa A Ferrante Brenlla, Ph.D., National Heart, Lung, and Blood Institute (NHLBI)📍 1 site📅 Started Apr 2022View details ↗
RecruitingNCT05103969 ↗
Cohort of Tumors With POLE/D1 Mutation
👨⚕️ Rosine GUIMBAUD, PhD.MD, Fédération francophone de Cancérologie digestive📍 1 site📅 Started Oct 2021View details ↗
MRI Study of Blood-brain Barrier Function in CADASIL
Enrolling by InvitationNCT04503213 ↗
A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation
Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability
👨⚕️ Eugenia Girda, MD, Rutgers Cancer Institute of New Jersey📍 2 sites📅 Started Mar 2018View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →